LifeStance appoints Ken Burdick as CEO/Chairman; founding CEO Michael Lester retires

LifeStance Health Group, Inc.

Ken Burdick appointed CEO and Chairman effective Sept 7, 2022; succeeds Michael Lester who retires as officer and director.
Danish Qureshi named President in addition to his role as COO.
Lester's Alert5 Consulting LLC receives $50,933.33/month consulting fee through Sept 7, 2023.
Burdick gets $700,000 base salary, target bonus 100% of base, and option for 9,404,539 shares with time/performance vesting.
Qureshi receives option for 2,821,362 shares with one-third time-based and two-thirds performance-based vesting.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Lester

President, Chief Executive Officer and Chairman

LFST · LifeStance Health Group, Inc.

Effective: 2022-09-07
Successor: Kenneth Burdick
Filed: September 8, 2022, 7:59 PM ET

Mr. Burdick succeeds Michael Lester, who has served as the Company’s President and Chief Executive Officer and Chairman since 2017 and who is retiring from his officer and director roles effective upon Mr. Burdick’s appointment on the Effective Date.

Role change

Danish Qureshi

President

LFST · LifeStance Health Group, Inc.

Effective: 2022-09-07
Filed: September 8, 2022, 7:59 PM ET

Danish Qureshi, the Company’s Chief Operating Officer, was appointed as the Company’s President, in addition to his role as Chief Operating Officer.

Appointed

Kenneth Burdick

Chief Executive Officer and Chairman of the Board

LFST · LifeStance Health Group, Inc.

Effective: 2022-09-07
Filed: September 8, 2022, 7:59 PM ET

appointed Kenneth Burdick as the Company’s new Chief Executive Officer and Chairman of the Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Lester departed as President, Chief Executive Officer and Chairman at LifeStance Health Group, Inc..

Action: retiring
Role: President, Chief Executive Officer and Chairman

Exact text from the filing

Mr. Burdick succeeds Michael Lester, who has served as the Company’s President and Chief Executive Officer and Chairman since 2017 and who is retiring from his officer and director roles effective upon Mr. Burdick’s appointment on the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Danish Qureshi was appointed as President at LifeStance Health Group, Inc..

Action: appointed
Role: President

Exact text from the filing

Danish Qureshi, the Company’s Chief Operating Officer, was appointed as the Company’s President, in addition to his role as Chief Operating Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Kenneth Burdick was appointed as Chief Executive Officer and Chairman of the Board at LifeStance Health Group, Inc..

Action: appointed
Role: Chief Executive Officer and Chairman of the Board

Exact text from the filing

appointed Kenneth Burdick as the Company’s new Chief Executive Officer and Chairman of the Board of Directors.

View on SEC.gov

LifeStance Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-240642

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.